- RNAC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
SC 13G Filing
Cartesian Therapeutics (RNAC) SC 13GSelecta Biosciences Inc
Filed: 30 Dec 19, 4:20pm
Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock, $0.0001 par value, of Selecta Biosciences, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filing.
Vivo Capital IX, LLC | |
December 30, 2019 | |
(Date) | |
/s/ Albert Cha | |
(Signature) | |
Managing Member | |
(Title) | |
Vivo Opportunity, LLC | |
December 30, 2019 | |
(Date) | |
/s/ Albert Cha | |
(Signature) | |
Managing Member | |
(Title) | |
Vivo Capital VIII, LLC | |
December 30, 2019 | |
(Date) | |
/s/ Albert Cha | |
(Signature) | |
Managing Member | |
(Title) |